Novavax, Inc. NVAX

NAS: NVAX | ISIN: US6700024010 19/03/2026

9,740 USD (-2,70%)

(-2,70%) 19/03/2026

Grafiek Novavax, Inc.

Grafiek Novavax, Inc.

1 dag1d -2,70%
1 week1w -4,84%
1 maand1m 5,87%
3 maanden3m 41,36%
6 maanden6m 9,81%
1 jaar1j 26,17%
5 jaar5j -95,89%

Novavax, Inc. in het nieuws

Toon enkel gratis nieuws

26 februari 2026 · Novavax to Participate in Upcoming Investor Conferences · Persbericht

26 februari 2026 · Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights · Persbericht

19 februari 2026 · Novavax to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 · Persbericht

20 januari 2026 · Novavax Announces Entering into a License Agreement with Pfizer · Persbericht

7 januari 2026 · Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference · Persbericht

12 november 2025 · Novavax to Participate in Jefferies London Healthcare Conference · Persbericht

6 november 2025 · Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights · Persbericht

4 november 2025 · Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid™, Triggering a $25 Million Milestone Payment · Persbericht

30 oktober 2025 · Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025 · Persbericht

22 oktober 2025 · Novavax Executes Planned Site Consolidation, Further Reducing Cost Footprint in Line with Corporate Strategy · Persbericht

Profiel Novavax, Inc.

Gezondheidstechnologie

Productie van biologische producten

Website: www.novavax.com

Hoofdzetel: Gaithersburg, Maryland Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe